Anonymous
Guest
Anonymous
Guest
We're closing in on another earnings announcement. The last one was the worst in Merck's history. I think this one will be even worse.
I'm betting we're at $42 per share a month from now, maybe lower. The market hasn't yet fully appreciated what a mess this company is.
I'm betting we're at $42 per share a month from now, maybe lower. The market hasn't yet fully appreciated what a mess this company is.